CARBON: UAB Cardiovascular Research Biobank
CARBON
UAB Cardiovascular Research Biobank
CARBON
UAB Cardiovascular Research Biobank
Sponsor study identifier
observational
500
1 country
1
Study Start
January 1, 2022
Actual (reported)Primary Completion
January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The UAB Cardiovascular Research Biobank (CARBON) will be a resource that contains biological materials, such as DNA samples, in addition to health and personal information on a large number of people over time. It will be set up so that it can be used in the future as a resource for researchers undertaking a wide range of medical research.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 23, 2021
Actual (reported)October 5, 2021
Actual (reported)January 1, 2022
Actual (reported)January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Genetic Variants in the NPPA and NPPB gene of the Natriuretic Peptide family associated with the Cardiovascular and Metabolic Diseases
Baseline
Individuals living in the Birmingham area will be enrolled through the University of Alabama at Birmingham campus. We will also enroll individuals who are associated with the University of Alabama at Birmingham.
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
Bajaj NS, Gutierrez OM, Arora G, Judd SE, Patel N, Bennett A, Prabhu SD, Howard G, Howard VJ, Cushman M, Arora P. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018 Jan 1;3(1):11-17. doi: 10.1001/jamacardio.2017.4207.
DNA, RNA, Plasma and Serum to be collected
Pankaj Arora, MD, FAHA
University of Alabama at Birmingham
First Submitted
September 23, 2021
First Posted
October 5, 2021
Study Start
January 1, 2022
Actual (reported)Primary Completion
January 1, 2030
EstimatedRole of Adiposomes in Endothelial Dysfunction
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 1, 2030
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
February 13, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: